{"result": "(\"entity\"<|>CASEN RECORDATI<|>ORGANIZATION<|>Casen Recordati is a commercial entity that produces special formulas for low-Phe diets in Spain.)\n##\n(\"entity\"<|>MEAD-JHONSON<|>ORGANIZATION<|>Mead-Jhonson is a company that offers various products for patients with phenylketonuria, including formulas for different age groups.)\n##\n(\"entity\"<|>MILUPA SA<|>ORGANIZATION<|>Milupa SA is a manufacturer of specialized dietary products for individuals with phenylketonuria.)\n##\n(\"entity\"<|>NUTRICIA SA<|>ORGANIZATION<|>Nutricia SA provides nutritional products, including those for low-Phe diets.)\n##\n(\"entity\"<|>SCIENTIFIC HOSPITAL SUPPLIES (SHS)<|>ORGANIZATION<|>Scientific Hospital Supplies (SHS) offers a range of dietary products for patients with phenylketonuria.)\n##\n(\"entity\"<|>VITAFLO ESPAÑA<|>ORGANIZATION<|>Vitaflo España specializes in nutritional products for individuals with metabolic disorders, including phenylketonuria.)\n##\n(\"entity\"<|>PHENYLKETONURIA<|>EVENT<|>Phenylketonuria is a metabolic disorder that requires dietary management to avoid phenylalanine.)\n##\n(\"entity\"<|>FENILALANINA<|>PERSON<|>Phenylalanine is an amino acid that must be managed in the diet of individuals with phenylketonuria.)\n##\n(\"entity\"<|>TIROSINA<|>PERSON<|>Tyrosine is an amino acid that is produced from phenylalanine and is important for individuals with phenylketonuria.)\n##\n(\"relationship\"<|>CASEN RECORDATI<|>PHENYLKETONURIA<|>Casen Recordati produces dietary products specifically designed for managing phenylketonuria<|>8)\n##\n(\"relationship\"<|>MEAD-JHONSON<|>PHENYLKETONURIA<|>Mead-Jhonson provides formulas that help manage phenylketonuria<|>8)\n##\n(\"relationship\"<|>MILUPA SA<|>PHENYLKETONURIA<|>Milupa SA manufactures specialized products for individuals with phenylketonuria<|>8)\n##\n(\"relationship\"<|>NUTRICIA SA<|>PHENYLKETONURIA<|>Nutricia SA offers nutritional solutions for managing phenylketonuria<|>8)\n##\n(\"relationship\"<|>SCIENTIFIC HOSPITAL SUPPLIES (SHS)<|>PHENYLKETONURIA<|>SHS provides dietary products for the management of phenylketonuria<|>8)\n##\n(\"relationship\"<|>VITAFLO ESPAÑA<|>PHENYLKETONURIA<|>Vitaflo España specializes in products for individuals with phenylketonuria<|>8)\n##\n(\"relationship\"<|>FENILALANINA<|>TIROSINA<|>Phenylalanine is converted into Tyrosine in the body, which is crucial for metabolic processes<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: PNAVB)14 (tablas 2 y 3).\nEl manejo de la Phe en la dieta PKU se suele hacer mediante un sistema de porciones o intercambios, lo más común suelen ser porciones de 50 mg, cantidad equivalente a 1 g de PNAVB y facilita mucho la confección de la dieta. Pero en aquellos casos en los que la tolerancia es menor puede interesar usar porciones de 10 mg.\nLo recomendable es que el aporte de Phe en la dieta se haga de la manera más homogénea posible a fin de evitar posibles descompensaciones en los niveles de Phe en sangre.\n\nb. Aportar el resto de aminoácidos en forma de preparados comerciales exentos de Phe: 1,5-3 g/kg día, en función de la edad, mínimo 5 tomas/día (tabla 1).\n\nEn los últimos años ha aumentado la variedad de estos preparados; estos presentan distintas características, lo cual permite una mayor adaptación a las necesidades del paciente.\nLas fórmulas especiales utilizadas en la actualidad para dietas de bajo contenido en Phe en España incluyen varias casas comerciales: Casen Recordati, Mead-Jhonson, Milupa SA, Nutricia SA, Scientific Hospital Supplies (SHS) y Vitaflo España.\nDisponen de distintos productos para las diferentes edades13.\nLa elección de una fórmula u otra va a depender de distintos factores, aparte de los factores más\n\nTabla 1. Listado de preparados comerciales para fenilcetonuria.\n\n| Presentación | Lactantes | Infantiles | Adultos |\n|--------------|-----------|------------|---------|\n| Polvo | Casen Fleet PKU1<br>Casen Fleet PKU Gel (> 6 meses)<br>Mead-Johnson Phenyl-free 1<br>PKU Anamix Infant (0-12 meses)<br>PKU Anamix Junior (1-10 años) | | |\n| | Sin lípidos | Con lípidos | Con alta concentración de proteínas |\n| Polvo | Casen Fleet PKU Gel<br>Vitaflo PKU Gel | Mead-Johnson Phenyl-free 2<br>Casen Fleet PKU Star<br>Casen Fleet PKU Star monodosis | |\n| Líquido | Vitaflo PKU Cooler 10 (> 3 años)<br>Vitaflo PKU Cooler 15 (> 3 años)<br>Vitaflo PKU Cooler 20 (> 3 años) | PKU Anamix Junior LQ (3-10 años) | |\n| Otros | SHS Phlexy-10 cápsulas (> 3 años) | SHS Phlexy-10 barras (> 3 años)<br>SHS Phlexy-10 tabletas (> 3 años) | |\n| Polvo | Casen Fleet PKU Gel<br>FleetPKU-Avant<br>FleetPKU-Avant Monodosis<br>Vitaflo PKU Express | Mead-Johnson Phenyl-free 2<br>Mead-Johnson Phenyl-free 2 HP<br>FleetPKU-Plus<br>FleetPKU-Plus Monodosis | Mead-Johnson Phenyl-free 2 HP |\n| Líquido | Vitaflo PKU Cooler 10<br>Vitaflo PKU Cooler 15<br>Vitaflo PKU Cooler 20<br>PKU Lophlex LQ 10 (a partir de 4 años y adultos, incluido mujeres embarazadas)<br>PKU Lophlex LQ 20 (a partir de 4 años y adultos, incluido mujeres embarazadas) | | |\n| Otros | SHS Phlexy-10 cápsulas | SHS Phlexy-10 barras<br>SHS Phlexy-10 tabletas | |\n---\nBLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\n```mermaid\ngraph LR\n    A[Fenilalanina] -->|PAH| B[Tirosina]\n    C[Biopterina] -->|BH4| A\n    A -->|DHPR| D[BH2]\n    E[Neopterina]\n    F[GTP]\n```\n\nFigura 1. Metabolismo de la fenilalanina.\nBH2: dihidrobiopterina; BH4: tetrahidrobiopterina;\nDHPR: dihidrobiopterin-reductasa; PAH: fenilalanina\nhidroxilasa.\n\nlógicos a tener en cuenta, como la edad, tolerancia a proteína de origen natural o necesidades energéticas, hay que tener en cuenta otra serie de factores relacionados con el día a día, como el grado de seguimiento de la dieta, el grado de actividad física o las preferencias del paciente.\n\nProteínas naturales de bajo valor biológico (patata, frutas, hortalizas y verduras): libres siempre que no se tomen en cantidades excesivamente elevadas.\n\nc. En algunos casos y situaciones concretas puede ser necesario suplementar la dieta. Existen preparados hipercalóricos exentos de proteínas (véase punto 3 del apartado 1)\n\nd. También puede ser necesario suplementar L-tirosina en algunos casos.\n\nTabla 2. Listado de alimentos para la fenilcetonuria\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}